Low-Dose ARAC, Donor Cells, and GM-CSF for Treatment of Recurrent Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation
Leukemia - United Kingdom
doi 10.1038/sj.leu.2403412
Full Text
Open PDFAbstract
Available in full text
Date
June 17, 2004
Authors
Publisher
Springer Nature